Amneal Handed 483 for Faulty Cleaning, Quality Procedures

Drug Industry Daily
A A
The FDA hit Amneal Pharmaceuticals with a Form 483 over cleaning, sanitation and quality control issues after an October inspection of the drugmaker’s Paterson, New Jersey facility.

To View This Article:

Login

Subscribe To Drug Industry Daily